CrossrefInfokarte
Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis
Drug Metabolism and Disposition · 2026-06 · 54 (6) · 100309
DOI: 10.1016/j.dmd.2026.100309 ↗Abstract
Kein Abstract verfügbar.
EUVIMED